First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
Shaodong Hong, Qiming J. Wang, Ying Cheng, Yongzhong Luo, Xiujuan Qu, Haibo Zhu, Zhenyu Ding, Xingya Li, Lin Wu, Yan Wang, Sheng Hu, Enwen Wang, Anwen Liu, Yuping Sun, Yun Fan, Feng Ye, Kaihua Lu, Jian Fang, Yuping Shen, Xiaoping Jin, Junyou Ge, Li Zhang, Wenfeng Fang
Topics & Concepts
Lung cancerMedicineOncologyInternal medicineCancer researchCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsImmunotherapy and Immune Responses